Srini Akkaraju, M.D., Ph.D.

Founder & Managing Partner

Samsara BioCapital

Jeremy Caldwell, Ph.D.

Managing Director

Red Tree Venture Capital

Mira Chaurushiya, Ph.D.

Managing Director

Westlake Village BioPartners

Alex Cogdill, MEng, Ph.D.

Head of Strategic Initiatives, Global Business Development

Daiichi Sankyo U.S.

Richard DiMarchi, Ph.D.

GLP-1 Biology Pioneer; Distinguished Professor, Indiana University

Jon Edwards, Ph.D.

Partner

Forbion

Richard Glynne, Ph.D.

Acting CEO, Belharra Therapeutics; President & CSO, Inception Therapeutics Discovery Engine; Venture Partner

Versant Ventures

Rachna Khosla

Senior Vice President, Business Development

Amgen

John Lepore, M.D.

CEO, ProFound Therapeutics; CEO-Partner

Flagship Pioneering

Tim Luker, Ph.D.

Vice President, Lilly Ventures, West Coast USA Head, Corp BD

Eli Lilly

Mathai Mammen, M.D., Ph.D.

Chairman, CEO & President

Parabilis Medicines

Fiona H. Marshall, Ph.D.

President, Biomedical Research

Novartis

Grace Han McMahon

AVP and Head, Pacific BD&L

Merck

David Moller

Venture Partner

Third Rock Ventures

Nikhil Mutyal, Ph.D.

Head of Search & Evaluation, Respiratory & Immunology

AstraZeneca

Deborah Palestrant, Ph.D.

Partner & Executive Chair, 4:59 Initiative

5AM Ventures

Sunil Patel

Head of Corporate Development and Business Development & Licensing

Merck

Andy Plump

President, Research & Development

Takeda Pharmaceutical Company Ltd.

Jeremy Quirk

VP BD&L Commercial Portfolio

GSK

Peter Schultz, Ph.D.

President, CEO & Professor of Chemistry

Scripps Research

Avi Spier, Ph.D.

Executive Director, Search & Evaluation

Novartis

Stephen Squinto

Chief Investment Officer

J.P. Morgan Asset Management

R. Scott Struthers, Ph.D.

Co-Founder and Chief Executive Officer

Crinetics Pharmaceuticals

Marc Tessier-Lavigne, Ph.D.

Co-Founder, Chairman & CEO

Xaira Therapeutics

Matt Tremblay, Ph.D.

Chief Executive Officer

Blackbird Laboratories

Fan Zhang, Ph.D.

Vice President of Business Development

Bristol Myers Squibb